Jonathan Waldstreicher

Jonathan Waldstreicher, a partner at ATP, has worked in medical devices as an entrepreneur, investor, and clinician. Jon founded Gala Therapeutics in 2015 and serves as the company's CEO. Prior to joining ATP, Jon was a director, Global Surgery R&D, at Johnson & Johnson. He started at Johnson & Johnson as an associate director in the Corporate Office of Science & Technology. Before medical school, Jon worked in Equity Research at Bear Stearns.

Jon received a BA from Brandeis University in economics and an MD and MBA from Tufts University School of Medicine. He completed a general surgery internship at Tufts Medical Center in Boston.